FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, particularly to a monoclonal antibody to 6-hemisuccinyl ether of morphine, capable of blocking the biological activity of morphine.
EFFECT: invention allows effective binding with morphine derivatives and inhibit biological activity of the drug.
3 cl, 2 dwg, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MONOCLONAL ANTIBODY 3K11 TO MORPHINE DERIVATIVES | 2018 |
|
RU2702002C1 |
| MONOCLONAL ANTI-IDIOTYPIC ANTIBODY AI-K11B, HAVING ANTIGENIC PROPERTIES OF MORPHINE | 2020 |
|
RU2745374C1 |
| MONOCLONAL ANTI-IDIOTYPIC ANTIBODY AI-G1, HAVING ANTIGENIC PROPERTIES OF MORPHINE | 2019 |
|
RU2717989C1 |
| IMMUNOGEN FOR TREATING AND PREVENTING OPIATE ADDICTION | 2013 |
|
RU2548802C1 |
| HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 (VEGFR1) ANTIBODY | 2023 |
|
RU2838680C1 |
| MONOCLONAL ANTIBODIES AND APPLICATIONS THEREOF | 2006 |
|
RU2432362C2 |
| MONOCLONAL ANTIBODIES TO C-END FRAGMENT OF ANTI-MULLER HORMONE | 2018 |
|
RU2765689C2 |
| MONOCLONAL ANTIBODY SS3-4 TO CONFORMATION HUMAN EPITOPE C3, STRAIN OF HYBRID MOUSE DNA RKKK(P)764D - PRODUCER OF MONOCLONAL ANTIBODY SS3-4 | 2015 |
|
RU2584582C1 |
| ANTIBODIES AGAINST HUMAN STABILIN-1 RECEPTOR | 2023 |
|
RU2823309C1 |
| MONOCLONAL ANTIBODIES AND METHODS OF USING THEM | 2017 |
|
RU2694412C2 |
Authors
Dates
2019-10-18—Published
2018-11-12—Filed